Busulfan
Top View
- Intravenous Busulfan and Melphalan, Tacrolimus, and Short-Course
- Inflammatory High-Risk Breast Cancer
- Seizures and Syncope in the Cancer Patient
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- Busulfan (Myleran®) (“Byoo SUL Fan”)
- Long-Term and Low-Dose of Busulfan Is a Safe and Effective Second-Line
- Clinical Implications for Cediranib in Advanced Cervical Cancer
- Emetogenic Potential of Antineoplastic Agents
- DRUG NAME: Busulfan
- Chemical Compatibility of Chemoclave™ and Chemolock™
- Pharmacogenetic Analysis of Liver Toxicity After Busulfan/Cyclophosphamide-Based Allogeneic Hematopoietic Stem Cell Transplantation
- A Phase IIA Study of the Addition of Temozolomide
- Evaluation of Novel Imidazotetrazine Analogues Designed to Overcome Temozolomide Resistance and Glioblastoma Regrowth Yulian P
- The Immunomodulatory Effects of Arsenic Trioxide in Autoimmunity and Alloreactivity Yishan Ye
- List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
- Trisenox, INN-Arsenic Trioxide
- Emetogenic Potential of Antineoplastic Agents
- Pharmaceuticals Utilized in Stem Cell Transplant